Julian W Woo
Examiner (ID: 14928, Phone: (571)272-4707 , Office: P/3731 )
Most Active Art Unit | 3771 |
Art Unit(s) | 3773, 3771, 3731, 3309 |
Total Applications | 2499 |
Issued Applications | 1786 |
Pending Applications | 354 |
Abandoned Applications | 359 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6804668
[patent_doc_number] => 20030232062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Method and composition to prevent and treat photoaging of skin'
[patent_app_type] => new
[patent_app_number] => 10/268801
[patent_app_country] => US
[patent_app_date] => 2002-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4999
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232062.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268801 | Method and composition to prevent and treat photoaging of skin | Oct 10, 2002 | Issued |
Array
(
[id] => 765545
[patent_doc_number] => 07008667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-07
[patent_title] => 'Bioactive agent release coating'
[patent_app_type] => utility
[patent_app_number] => 10/268163
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4267
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/008/07008667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268163
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268163 | Bioactive agent release coating | Oct 9, 2002 | Issued |
Array
(
[id] => 7226142
[patent_doc_number] => 20040072922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Rate limiting barriers for implantable medical devices'
[patent_app_type] => new
[patent_app_number] => 10/269004
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4109
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10269004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/269004 | Rare limiting barriers for implantable medical devices | Oct 8, 2002 | Issued |
Array
(
[id] => 7454259
[patent_doc_number] => 20040068000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Compression coated tablets'
[patent_app_type] => new
[patent_app_number] => 10/263161
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2345
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20040068000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263161 | Compression coated tablets | Oct 1, 2002 | Abandoned |
Array
(
[id] => 6824928
[patent_doc_number] => 20030235550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Antimicrobial compositions, products and methods employing same'
[patent_app_type] => new
[patent_app_number] => 10/263211
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9721
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263211 | Antimicrobial compositions, products and methods employing same | Oct 1, 2002 | Abandoned |
Array
(
[id] => 1282191
[patent_doc_number] => 06642276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-04
[patent_title] => 'Controlled release macrolide pharmaceutical formulations'
[patent_app_type] => B2
[patent_app_number] => 10/261564
[patent_app_country] => US
[patent_app_date] => 2002-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7591
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642276.pdf
[firstpage_image] =>[orig_patent_app_number] => 10261564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/261564 | Controlled release macrolide pharmaceutical formulations | Sep 29, 2002 | Issued |
Array
(
[id] => 693939
[patent_doc_number] => 07070804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Chewable tablet containing lysine'
[patent_app_type] => utility
[patent_app_number] => 10/254246
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2481
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/070/07070804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10254246
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/254246 | Chewable tablet containing lysine | Sep 24, 2002 | Issued |
Array
(
[id] => 6778166
[patent_doc_number] => 20030049247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Pharmaceutical composition comprising carriers for products based on vitamin-e, pa pain and hyaluronidase'
[patent_app_type] => new
[patent_app_number] => 10/182265
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2892
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182265 | Pharmaceutical composition comprising carriers for products based on vitamin-e, pa pain and hyaluronidase | Sep 23, 2002 | Abandoned |
Array
(
[id] => 6829296
[patent_doc_number] => 20030180354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Amlodipine maleate formulations'
[patent_app_type] => new
[patent_app_number] => 10/244048
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5735
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244048
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244048 | Amlodipine maleate formulations | Sep 12, 2002 | Abandoned |
Array
(
[id] => 6678219
[patent_doc_number] => 20030228360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Combination immediate release controlled release levodopa/carbidopa dosage forms'
[patent_app_type] => new
[patent_app_number] => 10/241837
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10513
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10241837
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/241837 | Combination immediate release controlled release levodopa/carbidopa dosage forms | Sep 11, 2002 | Issued |
Array
(
[id] => 6790136
[patent_doc_number] => 20030085480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Preparation of powder agglomerates'
[patent_app_type] => new
[patent_app_number] => 10/238423
[patent_app_country] => US
[patent_app_date] => 2002-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10794
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20030085480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10238423
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/238423 | Preparation of powder agglomerates | Sep 9, 2002 | Abandoned |
Array
(
[id] => 6778144
[patent_doc_number] => 20030049225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Goya mask for facials: a process for incorporating goya (momordica charantia) into generic paraffin and cosmetic clay for use in cosmetic facial masks and body wraps'
[patent_app_type] => new
[patent_app_number] => 10/236710
[patent_app_country] => US
[patent_app_date] => 2002-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 901
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10236710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/236710 | Goya derived cosmetic compositions for face and body | Sep 6, 2002 | Issued |
Array
(
[id] => 6668392
[patent_doc_number] => 20030113375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Pharmaceutical formulation and process'
[patent_app_type] => new
[patent_app_number] => 10/235392
[patent_app_country] => US
[patent_app_date] => 2002-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5353
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10235392
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/235392 | Pharmaceutical formulation and process | Sep 3, 2002 | Abandoned |
Array
(
[id] => 6739800
[patent_doc_number] => 20030157169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride'
[patent_app_type] => new
[patent_app_number] => 10/229645
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6199
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10229645
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/229645 | Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride | Aug 27, 2002 | Abandoned |
Array
(
[id] => 7398740
[patent_doc_number] => 20040039062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Urea, ruminally synthesizable mainly to microbial crude protein'
[patent_app_type] => new
[patent_app_number] => 10/227640
[patent_app_country] => US
[patent_app_date] => 2002-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3235
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039062.pdf
[firstpage_image] =>[orig_patent_app_number] => 10227640
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/227640 | Urea, ruminally synthesizable mainly to microbial crude protein | Aug 25, 2002 | Abandoned |
Array
(
[id] => 6860625
[patent_doc_number] => 20030091633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Methods and compositions for use of (S)-bisoprolol'
[patent_app_type] => new
[patent_app_number] => 10/225543
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13259
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225543 | Methods and compositions for use of (S)-bisoprolol | Aug 21, 2002 | Abandoned |
10/129640 | Heteroside polymer microgranules of marine origin containing various hydrophilic or hydrophobic substances, methods for using same in food, dietetic or pharmaceutical products | Aug 19, 2002 | Abandoned |
Array
(
[id] => 580820
[patent_doc_number] => 07445796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-04
[patent_title] => 'Pharmaceutically active particles of a monomodal particle size distribution and method'
[patent_app_type] => utility
[patent_app_number] => 10/223291
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2151
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/445/07445796.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223291 | Pharmaceutically active particles of a monomodal particle size distribution and method | Aug 18, 2002 | Issued |
Array
(
[id] => 891090
[patent_doc_number] => 07344734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Powder formulation'
[patent_app_type] => utility
[patent_app_number] => 10/223707
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7350
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/344/07344734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223707 | Powder formulation | Aug 18, 2002 | Issued |
Array
(
[id] => 7314719
[patent_doc_number] => 20040034094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Vitamin C stabilized topical formulation'
[patent_app_type] => new
[patent_app_number] => 10/223671
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3435
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223671 | Vitamin C stabilized topical formulation | Aug 15, 2002 | Abandoned |